Gestational Diabetes Mellitus

Endocrinol Metab Clin North Am. 2019 Sep;48(3):479-493. doi: 10.1016/j.ecl.2019.05.001. Epub 2019 Jun 18.

Abstract

Although it has been accepted for decades that women with gestational diabetes mellitus (GDM) are at high risk for future development of type 2 diabetes, vigorous debate regarding the value of detecting and treating GDM has persisted into the twenty-first century. Although results from 2 randomized trials provide strong evidence that treating GDM reduces adverse perinatal outcomes, it remains to be determined whether treatment impacts long-term offspring outcomes. Insulin is the first-line pharmacologic treatment and is added when glycemic goals are not met with nutritional modifications. Oral agent use is controversial, as data on long-term offspring outcomes are lacking.

Keywords: Diagnosis; Gestational diabetes mellitus; Offspring; Outcomes; Pregnancy; Treatment.

Publication types

  • Review

MeSH terms

  • Blood Glucose / metabolism
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / epidemiology
  • Diabetes Mellitus, Type 2 / etiology
  • Diabetes Mellitus, Type 2 / therapy
  • Diabetes, Gestational* / diagnosis
  • Diabetes, Gestational* / epidemiology
  • Diabetes, Gestational* / therapy
  • Female
  • Humans
  • Insulin / therapeutic use
  • Pregnancy
  • Pregnancy Outcome / epidemiology
  • Puerperal Disorders / etiology
  • Puerperal Disorders / prevention & control

Substances

  • Blood Glucose
  • Insulin